• research
• publications

Publications

• Sharma NK, Li T, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. Intensity-Modulated Radiotherapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 2. [Epub ahead of print]. PubMed
• Canter D, Greenberg RE, Horwitz EM, Kutikov A, Li J, Long C, Buyyounouski M, Boorjian SA. Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT. Can J Urol. 2010 Oct;17(5):5365-9. PubMed
• Buyyounouski MK. Androgen deprivation therapy in high-risk prostate cancer. Oncology (Williston Park). 2010 Aug;24(9):806, 809. PubMed
• Buyyounouski MK, Balter P, Lewis B, D'Ambrosio DJ, Dilling TJ, Miller RC, Schefter T, Tomé W, Harris EE, Price RA Jr, Konski AA, Wallner PE. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):3-10. Epub 2010 Jul 17. PubMed
• Buyyounouski MK. Radiotherapy: PSA nadir predicts long-term mortality. Nat Rev Clin Oncol. 2010 Apr;7(4):188-90. PubMed
• Buyyounouski MK, Price RA Jr, Harris EE, Miller R, Tomé W, Schefter T, Parsai EI, Konski AA, Wallner PE. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1297-304. PubMed
• Williams SG, Pickles T, Buyyounouski MK. Androgen deprivation therapy and prostate cancer duration. J Clin Oncol. 2009 Dec 1;27(34):e228; author reply e229. Epub 2009 Nov 2. PubMed
• Sharma NK, Cohen RJ, Eade TN, Buyyounouski MK, Uzzo RG, Li J, Crawford K, Chen DY, McNeeley S, Horwitz EM. An intraoperative real-time sleeved seed technique for permanent prostate brachytherapy. Brachytherapy. 2010 Apr-Jun;9(2):126-30. Epub 2009 Oct 21. PubMed
• Li JS, Jin L, Pollack A, Horwitz EM, Buyyounouski MK, Price RA Jr, Ma CM. Gains from real-time tracking of prostate motion during external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1613-20. Epub 2009 Oct 14. PubMed
• Buyyounouski MK. Surveillance for stage I seminoma: better the devil you know than the devil you don't? Oncology (Williston Park). 2009 Aug;23(9):762, 764. PubMed
• Kaplan DJ, Boorjian SA, Ruth K, Egleston BL, Chen DY, Viterbo R, Uzzo RG, Buyyounouski MK, Raysor S, Giri VN. Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population. BJU Int. 2010 Feb;105(3):334-7. Epub 2009 Aug 25. PubMed
• Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. PubMed
• Giri VN, Egleston B, Ruth K, Uzzo RG, Chen DY, Buyyounouski M, Raysor S, Hooker S, Torres JB, Ramike T, Mastalski K, Kim TY, Kittles R. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila). 2009 Mar;2(3):244-50. Epub 2009 Feb 24. PubMed
• Wang L, Hayes S, Paskalev K, Jin L, Buyyounouski MK, Ma CC, Feigenberg S. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage. Radiother Oncol. 2009 Jun;91(3):314-24. PubMed
• Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):383-7. PubMed
• D'Ambrosio DJ, Li T, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does treatment duration affect outcome after radiotherapy for prostate cancer? Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1402-7. PubMed
• Kaplan DJ, Crispen PL, Greenberg RE, Chen DY, Viterbo R, Buyyounouski MK, Horwitz EM, Uzzo RG. Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens. Urology. 2008 Sep;72(3):654-8. PubMed
• D'Ambrosio DJ, Ruth K, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer? Urology. 2008 May;71(5):938-41. PubMed
• Eade TN, Horwitz EM, Ruth K, Buyyounouski MK, D'Ambrosio DJ, Feigenberg SJ, Chen DY, Pollack A. A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant. Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):338-45. PubMed
• D'Ambrosio DJ, Ruth K, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier? Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1487-91. PubMed
• Sharma NK, Li T, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. Intensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):S10. PubMed
• Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008 Jan 1;112(1):55-60. PubMed
• Williams SG, Buyyounouski MK, Pickles T, Kestin L, Martinez A, Hanlon AL, Duchesne GM. Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1169-75. PubMed
• Buyyounouski MK, Hanlon AL, Horwitz EM, Pollack A. Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):59-66. PubMed
• Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG, Hanks G, Godwin AK, Chen DY, Gordon R, Cescon T, Raysor S, Watkins-Bruner D. Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol. 2007 Nov;178(5):1920-4; discussion 1924. PubMed
• Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy. Cancer. 2007 Jul 1;110(1):68-80. PubMed
• D'Ambrosio DJ, Cohen RB, Glass J, Konski A, Buyyounouski MK, Feigenberg SJ. Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case report. J Neurooncol. 2007 Oct;85(1):77-9. PubMed
• Eade TN, Al-Saleem T, Horwitz EM, Buyyounouski MK, Chen DY, Pollack A. Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate. Cancer. 2007 May 15;109(10):2011-5. PubMed
• Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A. What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):682-9. PubMed
• D'Ambrosio DJ, Hanlon AL, Al-Saleem T, Feigenberg SJ, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1082-7. PubMed
• Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Radiation dose and late failures in prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1074-81. PubMed
• Alcantara P, Hanlon A, Buyyounouski MK, Horwitz EM, Pollack A. Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death. Cancer. 2007 Jan 1;109(1):41-7. PubMed
• Price RA Jr, Hannoun-Levi JM, Horwitz E, Buyyounouski M, Ruth KJ, Ma CM, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):583-92. PubMed
• Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA Jr. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):518-26. PubMed
• Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A. Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1455-62. PubMed
• Buyyounouski MK, Hanlon AL, Horwitz EM, Uzzo RG, Pollack A. Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1291-8. PubMed
• Buyyounouski MK, Klump WJ, Konski A, Wu H, Adler LP. FDG PET imaging of signet-ring cell adenocarcinoma of the stomach. Clin Nucl Med. 2005 Feb;30(2):118-9. PubMed
• Buyyounouski MK, Hanlon AL, Price RA Jr, Horwitz EM, Feigenberg SJ, Pollack A. In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1664-5. PubMed
• Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon AL, Milestone BN, Pollack A. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1383-91. PubMed
• Buyyounouski MK, Horwitz EM, Price RA, Hanlon AL, Uzzo RG, Pollack A. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):743-9. PubMed
• Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Re: improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the search database. J Urol. 2004 Mar;171(3):1246-7. PubMed
• Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Positive prostate biopsy laterality and implications for staging. Urology. 2003 Aug;62(2):298-303. PubMed
• Kaminski JM, Nguyen K, Buyyounouski M, Pollack A. Prostate cancer gene therapy and the role of radiation. Cancer Treat Rev. 2002 Feb;28(1):49-64. PubMed
• Rubin MA, Buyyounouski M, Bagiella E, Sharir S, Neugut A, Benson M, de la Taille A, Katz AE, Olsson CA, Ennis RD. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology. 1999 Mar;53(3):542-7. Review. PubMed

Book Chapters

• Loehrer P, Jayaram N, Dash A, Buyyounouski MK, Skarecky D. Testicular Cancer. In: Cancer Management: A Multidisciplinary Approach, 13 Ed. R Pazdur, L Wagman, K Cammphausen, W Hoskins (eds.), CMPMedica, Norwalk, CT, In Press. [Book Chapter]
• Loehrer P, Jayaram N, Dash A, Buyyounouski MK, Skarecky D. Testicular Cancer. In: Cancer Management: A Multidisciplinary Approach, 12 Ed. R Pazdur, L Wagman, K Cammphausen, W Hoskins (eds.), CMPMedica, Norwalk, CT, 2009. [Book Chapter]
• Buyyounouski MK, Horwitz EM. MRI Target Delineation in Prostate Cancer. In IGRT: A Clinical Perspective. AJ Mundt et al. (Eds) In Preparation. [Book Chapter]
• Buyyounouski MK. Comment on influence of local tumor control as assessed by post-treatment prostate biopsies after external beam radiotherapy for prostate cancer on distant metastases and cancer related mortality. J Urol. 2008 Feb 18. [Invited Editorial]
• Loehrer P, Ahlering T, Buyyounouski MK. Testicular Cancer. In: Cancer Management: A Multidisciplinary Approach, 11th Ed. R Pazdur, L Coia, L Wagman, W Hoskins (eds.), PRR Treatment Handbook. PRR, Huntington, NY, 2008. [Book Chapter]
• Buyyounouski MK, Horwitz, EH, Pollack A. Prostate. In: Handbook of Radiation Oncology. BG Haffty, LD Wilson (eds.), Jones and Bartlett, 2008. [Book Chapter]
• Loehrer P, Ahlering T, Buyyounouski MK. Testicular Cancer. In: Cancer Management: A Multidisciplinary Approach, 10th Ed. R Pazdur, L Coia, L Wagman, W Hoskins (eds.), PRR Treatment Handbook. PRR, Huntington, NY, 2007. [Book Chapter]
• Buyyounouski MK, Horwitz EM, Price Jr RA, Feigenberg SJ and Pollack A. Prostate IMRT. In IMRT Handbook: Concepts & Clinical Applications. Bortfeld T, Rupert Schmidt-Ullrich R, de Neve W, Wazer DE (Eds). Springer-Verlag Heidelberg, Germany, 2006. [Book Chapter]
• Buyyounouski MK and Pollack A. External Beam Radiation Therapy for Prostate Cancer. In Atlas of the Prostate; 3rd Ed. Current Medicine LLC, Philadelphia, USA, 2006. [Book Chapter]